Alzheimer's drug shows promise in early results of study
Shares of Biogen and other drugmakers researching Alzheimer's disease have soared after Japan's Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-…
Shares of Biogen and other drugmakers researching Alzheimer's disease have soared after Japan's Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-…